BNP Paribas Has $5.15 Million Position in CVS Health Corporation $CVS

Key Points

• BNP Paribas more than doubled its CVS Health position in the second quarter, acquiring 25,617 additional shares for a total holding of 49,971 shares valued at approximately $5.15 million. Institutional investors and hedge funds collectively own 80.66% of CVS.
• CVS reported stronger-than-expected quarterly results, with adjusted earnings of $2.58 per share versus the $1.87 consensus estimate and revenue of $106.1 billion, up 7.3% year over year. The company reaffirmed fiscal 2026 EPS guidance of $7.90 to $8.10.
• Analysts remain generally optimistic, with 22 Buy ratings and two Holds producing a “Moderate Buy” consensus and an average price target of $107.17. CVS also pays a quarterly dividend of $0.665 per share, representing a 2.9% annualized yield.

BNP Paribas raised its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 105.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 49,971 shares of the pharmacy operator's stock after purchasing an additional 25,617 shares during the quarter. BNP Paribas' holdings in CVS Health were worth $5,154,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the business. Handelsbanken Fonder AB boosted its holdings in CVS Health by 83.6% in the 2nd quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator's stock worth $112,729,000 after acquiring an additional 496,124 shares during the period. State Street Corp increased its position in shares of CVS Health by 2.1% during the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator's stock worth $4,776,182,000 after acquiring an additional 1,245,457 shares during the last quarter. Legal & General Group Plc lifted its stake in shares of CVS Health by 0.3% in the fourth quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator's stock worth $738,777,000 after acquiring an additional 31,249 shares in the last quarter. Deutsche Bank AG increased its stake in shares of CVS Health by 28.4% in the fourth quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator's stock worth $370,333,000 after buying an additional 1,031,998 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. acquired a new stake in shares of CVS Health in the 2nd quarter valued at about $49,622,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Pharmacy momentum supports the turnaround case. Rising prescription volumes, gains associated with Rite Aid and improving pharmacy profitability could provide support for CVS’s second-half outlook. This adds to the company’s recent earnings momentum, including revenue growth and an earnings beat in its latest reported quarter. How CVS' Pharmacy and Consumer Wellness Is Positioned for H2 2026
• Positive Sentiment: Updated flu vaccines are now available nationwide. CVS Pharmacy and MinuteClinic are offering the 2026–2027 vaccines, while expanded testing and treatment services may increase seasonal customer traffic. A company survey found that more than 60% of consumers are likely to get a flu shot, though the earnings effect is likely to be seasonal and modest. CVS Pharmacy and MinuteClinic Now Offering Updated Flu Vaccines Nationwide
• Positive Sentiment: Value-focused coverage is reinforcing rebound expectations. Zacks characterizes CVS as a potential long-term value stock, while Trefis notes that the company’s historical drawdowns have often eventually recovered. These are sentiment and valuation arguments rather than new financial guidance, but they may attract investors seeking a healthcare turnaround at a relatively reasonable valuation. Why CVS Health Is a Top Value Stock for the Long-Term
• Neutral Sentiment: ACA insurer exits create both opportunity and uncertainty. Cigna, Molina and other carriers are leaving Obamacare exchanges in 2027. The disruption could create enrollment opportunities for Aetna, CVS’s insurance business, but also highlights regulatory, pricing and membership risks across the sector. All the Insurers Exiting ACA Obamacare Exchanges for 2027
• Negative Sentiment: Political pressure on vertically integrated healthcare companies remains a risk. Mark Cuban’s support for breaking up “big medicine” adds to scrutiny of insurers, pharmacy benefit managers and large healthcare platforms. No specific policy action against CVS was announced, but potential structural or regulatory changes could weigh on sentiment. Mark Cuban Backs Plan to Break Up Big Medicine

CVS Health Trading Up 0.2%

CVS Health stock opened at $93.15 on Friday. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The company's fifty day moving average price is $101.42 and its two-hundred day moving average price is $89.46. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The company has a market capitalization of $119.14 billion, a price-to-earnings ratio of 24.64, a PEG ratio of 0.91 and a beta of 0.61.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. The business had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm's revenue for the quarter was up 7.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health's payout ratio is currently 70.37%.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of research reports. Robert W. Baird set a $107.00 price target on CVS Health in a research report on Thursday, August 6th. Wall Street Zen upgraded shares of CVS Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 8th. JPMorgan Chase & Co. lifted their price objective on shares of CVS Health from $111.00 to $118.00 and gave the company an "overweight" rating in a research report on Wednesday, August 12th. Cantor Fitzgerald lifted their price target on CVS Health from $100.00 to $110.00 and gave the company an "overweight" rating in a report on Tuesday, July 7th. Finally, Mizuho boosted their price objective on CVS Health from $110.00 to $115.00 and gave the stock an "outperform" rating in a research report on Monday, June 8th. Twenty-two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and a consensus target price of $107.17.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source